deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT03535675

Muscadine Plus (MPX) In Men With Prostate Cancer

A Randomized Double-Blind, Placebo-Controlled Study Of The Effects Of MPX Capsules On Rising Prostate-Specific Antigen Levels In Alanine/Alanine SOD2 Genotype Men Following Initial Therapy For Prostate Cancer

Sponsor: Greater Washington Community Foundation

Updated 19 times since 2018 Last updated: May 18, 2023 Started: Oct 30, 2018 Primary completion: Jul 6, 2022 Completion: Nov 3, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was terminated by DSMB due to futility.

A PHASE3 clinical study on Adenocarcinoma of the Prostate, this trial is terminated or withdrawn. The trial is conducted by Greater Washington Community Foundation and has accumulated 19 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Mar 2019 · 3 months · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~May 2020 · 8 months · monthly snapshot~May 2020 – ~Aug 2020 · 3 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Nov 2021 · 6 months · monthly snapshot~Nov 2021 – ~Mar 2022 · 4 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~Jun 2023 · 5 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

19 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jun 2023 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jan 2023 — Jun 2023 [monthly]

    Terminated PHASE3

    Status: Active Not RecruitingTerminated

Show 14 earlier versions
  1. Sep 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  2. Mar 2022 — Sep 2022 [monthly]

    Recruiting PHASE3

  3. Nov 2021 — Mar 2022 [monthly]

    Recruiting PHASE3

  4. May 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE3

  6. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  7. May 2020 — Aug 2020 [monthly]

    Recruiting PHASE3

  8. Sep 2019 — May 2020 [monthly]

    Recruiting PHASE3

  9. Jul 2019 — Sep 2019 [monthly]

    Recruiting PHASE3

  10. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE3

  11. Mar 2019 — Jun 2019 [monthly]

    Recruiting PHASE3

  12. Dec 2018 — Mar 2019 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  13. Oct 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE3

  14. Jun 2018 — Oct 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Greater Washington Community Foundation
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Data source: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

For direct contact, visit the study record on ClinicalTrials.gov .